Dual-Modality Computational Ophthalmic Imaging with Deep Learning and Coaxial Optical Design

The growing burden of myopia and retinal diseases necessitates more accessible and efficient eye screening solutions. This study presents a compact, dual-function optical device that integrates fundus photography and refractive error detection into a unified platform. The system features a coaxial optical design using dichroic mirrors to separate wavelength-dependent imaging paths, enabling simultaneous alignment of fundus and refraction modules. A Dense-U-Net-based algorithm with customized loss functions is employed for accurate pupil segmentation, facilitating automated alignment and focusing. Experimental evaluations demonstrate the system's capability to achieve high-precision pupil localization (EDE = 2.8 px, mIoU = 0.931) and reliable refractive estimation with a mean absolute error below 5%. Despite limitations due to commercial lens components, the proposed framework offers a promising solution for rapid, intelligent, and scalable ophthalmic screening, particularly suitable for community health settings.

Pneumonia App: a mobile application for efficient pediatric pneumonia diagnosis using explainable convolutional neural networks (CNN)

Mycoplasma pneumoniae pneumonia (MPP) poses significant diagnostic challenges in pediatric healthcare, especially in regions like China where it's prevalent. We introduce PneumoniaAPP, a mobile application leveraging deep learning techniques for rapid MPP detection. Our approach capitalizes on convolutional neural networks (CNNs) trained on a comprehensive dataset comprising 3345 chest X-ray (CXR) images, which includes 833 CXR images revealing MPP and additionally augmented with samples from a public dataset. The CNN model achieved an accuracy of 88.20% and an AUROC of 0.9218 across all classes, with a specific accuracy of 97.64% for the mycoplasma class, as demonstrated on the testing dataset. Furthermore, we integrated explainability techniques into PneumoniaAPP to aid respiratory physicians in lung opacity localization. Our contribution extends beyond existing research by targeting pediatric MPP, emphasizing the age group of 0-12 years, and prioritizing deployment on mobile devices. This work signifies a significant advancement in pediatric pneumonia diagnosis, offering a reliable and accessible tool to alleviate diagnostic burdens in healthcare settings.